Oracle Investment Management as of Sept. 30, 2016
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 17 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 21.4 | $139M | 5.1M | 27.26 | |
| Tesaro | 17.8 | $116M | 1.2M | 100.24 | |
| Mazor Robotics Ltd. equities | 11.0 | $72M | 2.8M | 25.87 | |
| NxStage Medical | 10.3 | $67M | 2.7M | 24.99 | |
| Quidel Corporation | 8.6 | $56M | 2.5M | 22.09 | |
| Opko Health (OPK) | 7.4 | $48M | 4.5M | 10.59 | |
| Pacific Biosciences of California (PACB) | 6.9 | $45M | 5.0M | 8.96 | |
| Biolase Technology | 3.5 | $23M | 14M | 1.59 | |
| Amarin Corporation (AMRN) | 3.0 | $19M | 6.1M | 3.19 | |
| Intrexon | 2.9 | $19M | 663k | 28.02 | |
| Accuray Incorporated (ARAY) | 2.4 | $16M | 2.5M | 6.37 | |
| shares Agenus | 2.2 | $14M | 2.0M | 7.18 | |
| Vermillion | 1.7 | $11M | 8.6M | 1.30 | |
| Contrafect | 0.5 | $2.9M | 1.2M | 2.48 | |
| Biogen Idec (BIIB) | 0.3 | $2.1M | 6.7k | 313.10 | |
| Second Sight Med Prods | 0.0 | $179k | 51k | 3.52 | |
| ZIOPHARM Oncology | 0.0 | $38k | 6.7k | 5.70 |
